NDTP's Mark Kester Left the PennState venture capital, Ellington Healthcare firm 15 years ago to start the State of Penn Biotech incubation center and the Keystone Nano Biotech firm (last reported to have multiple FDA cancer trials including a phase III trial 16 months ago),
and the firm (Ellington Healthcare) he left 15 years ago, and is now with again, (In addition to NDTP, the Ag-Nano-Tech-Firm he helped spawn with a Student and the third that has the ex Keystone Nano CEO and just one Phase II Breast cancer trial), all spent 15 years and $$$$$$$$$$ of private and federal-University grant money developing the PennState Ceramide patented anti cancer, LSD-disease Nano-tech, and as of July last year were working on use of the Ceramides to treat Covid19, all pre NDTP's Filling in coming days/weeks.
Dr Mark Kester's and CCA, LLC's private Biotech research spans 40, 11 and 8 years already.
It is obvious to me NDTP is ready for the revenue spot light stage now. Revenue can be billion dollar licenses of the Nano-Liposome-ceramide Fed-Exp delivery Nano tech to 350 Billion dollar drug firms like Novartis, for use to deliver their drugs...
NDTP does not need to build or manufacture anything. There is massive Toll manufacturing capacity already available.
"Ok everyone.. I have a question>>>>
Not ever having started a Biotech company from scratch, does anyone know how long typically it would take? (6 months, 1 year, 2 years?)
Factor in all the legal paperwork, getting contracts made, buildings acquired, equipment bought etc...
As NDTP part owners, what kind of timeline makes sense? I know we've all been waiting for official news, and I understand the reason why we haven't heard anything. Ecomike says it could be anything from the end of Feb to the end of March as to filings.
What I'm asking is what would it take to get a fully manufacturing company as a going concern."
Google Toll "Manufacturing, Drinks, drugs, foods".
Walmart does not make anything, they sell private label Chinese Orange Juice using Toll Manufacturers, with the Walmart label on it.
The US has massive empty building Capacity. Nothing needs to be built.
NDTP has an 8 year JV deal with UPennMed Research Hospital.
The 450 Million dollars of Bio-tech assets NDTP bought is not "a going concern" It will/must include $40 Mil in cash for some of those shares as required for the NYSE uplist. That had to be the first thing they did, before moving CCA, LLC and later Keystone Nano assets into the shell.
The synergism of the 2, Cancer-ceramides and the TBI/BBB/crossing Nano tech is worth 20 times more being in the same company, as the 2 parts.
Just the shock and awe of the entire story of this 292K float, no new float shares for 12 Months or more, makes this an easy run to $100 /share this year. $300 if Kester came up with a Ceramide / covid19 product and brought it to NDTP.Or they announce the two techs being able to tackle brain cancer as well as TBI-brain injury.
Drugman's $2 Trillion dollar market analysis weeks ago, was not wrong, if we get/got all the goodies under one hood.
News 
Market Data 
Discover 
